Showing results (471-480 of 542) with videos related to

Sort By:
Pageof 55
Atherosclerosis|February 5, 2000
Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI ParisO Perez-Mendez, E Bruckert, G Franceschini, et al.
Molecular and Cellular Biology|July 20, 1999
Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolismL Fajas, K Schoonjans, L Gelman, et al.
European Journal of Clinical Investigation|July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawalM Välimäki, J Kahri, K Laitinen, et al.
Journal of Lipid Research|October 1, 1995
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du MyocardeR Jemaa, F Fumeron, O Poirier, et al.
The EMBO Journal|October 1, 1996
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase geneK Schoonjans, J Peinado-Onsurbe, A M Lefebvre, et al.
Diabetes, Obesity & Metabolism|January 12, 2005
The anti-obesity effect of rimonabant is associated with an improved serum lipid profileB Poirier, J-P Bidouard, C Cadrouvele, et al.
Atherosclerosis|December 23, 1998
Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteinsS Nion, L Demoor, C Boutillon, et al.
Journal of Cardiovascular Pharmacology|October 22, 1998
A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cellsE Walters-Laporte, C Furman, S Fouquet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 4, 1999
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patientsF D Brites, E Cavallero, C de Geitere, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemiaJ M Bard, G Luc, P Douste-Blazy, et al.
Pageof 55